Devices › Device types
FDA product code MEG · class 2 · General Hospital
Syringe, antistick: medical device reports filed with FDA
2,952 reports carry this product code, 2000–2026; 12 brands with a page.
- 2,952
- reports with this product code
- 0% of all MAUDE reports
- 96
- reports, 12 months to August 2026
- 177 in the 12 months before
- 88.1%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code MEG is FDA's classification for "Syringe, antistick" (general Hospital panel), a class 2 device. 2,952 medical device reports carry this product code, 0% of the MAUDE database, from February 2000 to August 2026.
96 reports arrived in the 12 months to August 2026, down 46% from 177 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.1%), injury (8.7%) and other (2%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Bd Integra Syringe With Detachable Needle | 247 | 0 | 0% | 83.1% |
| VanishPoint | 153 | 9 | 0% | 95.7% |
| Sol-Millennium | 56 | 5 | 0% | 100% |
| BD SafetyGlide | 42 | 127 | 0% | 98.4% |
| Bd Insulin Syringe With The Bd Ultra-Fine Needle | 6 | 0 | 0% | 97.5% |
| Jelco | 4 | 34 | 0% | 84.3% |
| Monoject | 3 | 14 | 0.2% | 88.4% |
| Bd Precisionglide Needle | 2 | 0 | 0% | 95.9% |
| Magellan | 2 | 20 | 0% | 95.2% |
| Portex | 2 | 8 | 0.6% | 80.6% |
| Bd Insulin Syringes With Bd Ultra-Fine Needle | 1 | 0 | 0% | 99.2% |
| Spectrum Infusion Pump | 1 | 15 | 0% | 99.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Becton Dickinson Medical Systems | 642 | 21.7% |
| Bd Medical - Diabetes Care | 286 | 9.7% |
| Becton Dickinson | 67 | 2.3% |
| Bd Medical Bd West Medical Surgical | 33 | 1.1% |
| Bd | 19 | 0.6% |
| Becton Dickinson And | 19 | 0.6% |
| Terumo Medical | 8 | 0.3% |
| Smiths Medical | 6 | 0.2% |
| Mhc Medical Products | 4 | 0.1% |
| Becton Dickinson Ind Cirurgicas Ltda | 2 | 0.1% |
| Becton Dickinson Infusion Therapy Systems | 2 | 0.1% |
| Becton Dickinson & Bd | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Leak/splashthe device leaked | 521 | 17.6% |
| Breakthe device broke | 387 | 13.1% |
| Difficult or delayed activation | 352 | 11.9% |
| Retraction problem | 314 | 10.6% |
| Fluid/blood leak | 114 | 3.9% |
| Detachment of device component | 101 | 3.4% |
| Detachment of device or device componentpart of the device came off | 93 | 3.2% |
| Fail-safe problem | 90 | 3% |
| Device contamination with chemical or other material | 75 | 2.5% |
| Failure to deliverthe device did not deliver the dose or item | 68 | 2.3% |
| Activation problem | 67 | 2.3% |
| Defective devicethe device was defective | 66 | 2.2% |
| Activation failure | 56 | 1.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 54 | 1.8% |
| Defective component | 50 | 1.7% |
| Device contaminated during manufacture or shipping | 46 | 1.6% |
| Material protrusion/extrusion | 46 | 1.6% |
| Device markings/labelling problema problem with the device markings or label | 37 | 1.3% |
| Material twisted/bent | 35 | 1.2% |
| Bent | 34 | 1.2% |
Questions about syringe, antistick reports
What is product code MEG?
FDA's classification code for "Syringe, antistick", class 2, reviewed by the general Hospital panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,952 reports through August 2026, 96 of them in the latest 12 months.
Which brands appear most often?
Bd Integra Syringe With Detachable Needle (247), VanishPoint (153), Sol-Millennium (56), BD SafetyGlide (42) and Bd Insulin Syringe With The Bd Ultra-Fine Needle (6). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.